The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study

AIM: To compare the early biochemical response and rate of adverse effects in patients who received prednisolone (PRED)/azathioprine (AZA) and those who received budesonide (BUD)/AZA as the first-line treatment for autoimmune hepatitis. METHODS: The study involved 25 patients receiving PRED 30 mg/da...

Descripción completa

Detalles Bibliográficos
Autores principales: Binicier, Ömer Burcak, Günay, Süleyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734566/
https://www.ncbi.nlm.nih.gov/pubmed/31483120
http://dx.doi.org/10.3325/cmj.2019.60.345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734566/
https://www.ncbi.nlm.nih.gov/pubmed/31483120
http://dx.doi.org/10.3325/cmj.2019.60.345

Ejemplares similares